Detection of aberrant methylation of tumor suppressor genes in plasma from cancer patients

Conclusion Our results indicate that the frequency of methylation of cancer-related genes is dependent on the type of cancer and patient. Therefore, DNA methylation of cancer-related genes has a high potential as a biomarker for personalized medicine.
Source: Personalized Medicine Universe - Category: Drugs & Pharmacology Source Type: research